Anti-Human CD276 Therapeutic Antibody (Enoblituzumab)

Recombinant monoclonal antibody to CD276. Enoblituzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors.
Supplier Creative Biolabs
Product # TAB-424CQ
Pricing Inquiry
Host Human
Target CD276
Species Reactivity Human
Type IgG1, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback